The NanoStrand Clinical Study

Paused · Not applicable

Conditions studied: Disc Degeneration;Cervical

In brief

A prospective, multi-center, randomized, self-controlled, single-blinded, clinical study evaluating the NanoMetalene implant as compared to the PEEK and allograft implants in ACDF for the treatment of cervical degenerative disc disease (DDD).

Key facts

Study ID
NCT03871400
Run by
SeaSpine, Inc.
People needed
18
Starts
2018-11-18
Expected to finish
2021-01-30
Last updated by the study team
2020-10-19

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.